Boston Sci, Bard Link Up To Contend With Medtronic In Drug-Coated Balloons
This article was originally published in The Gray Sheet
Executive Summary
The deal will help Bard compete against Medtronic’s recently launched IN.PACT Admiral paclitaxel-coated peripheral angioplasty balloon and will give Boston Sci a much earlier chance than expected to compete in the DCB market.